A delay in diagnosis and treatment of vulvovaginitis can have big impacts on a patient’s quality of life and their overall health. Explore how screening modalities like molecular tests and treatment guidelines from the CDC can help optimize the management of patients with vulvovaginitis with Dr. Charles Turck and Dr. Tosin Goje, Associate Professor of Obstetrics and Gynecology and Reproductive Biology at the Cleveland Clinic’s Lerner College of Medicine at Case Western Reserve University.